Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Takeda Pharmaceuticals USA Inc. v. Watson Laboratories Inc.
Case Number:
1:14-cv-00268
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
January 12, 2016
Takeda's Gout Drug IP Case Paused After Deal With Watson
A Delaware federal judge on Tuesday pushed pause on Takeda's patent infringement suit seeking to block Watson Laboratories from producing a generic version of the gout treatment Colcrys after the parties reached a settlement that is pending review by federal regulators.
-
February 28, 2014
Takeda Accuses Watson Of Stepping On Gout Drug Patents
Takeda Pharmaceuticals USA Inc. on Thursday launched a patent infringement suit against Watson Laboratories Inc. in Delaware federal court, seeking to prevent the generic-drug company from producing its own version of the gout treatment Colcrys.